Attovia Therapeutics

About:

Attovia Therapeutics develops a pipeline of biotherapeutics for immune-mediated diseases.

Website: https://www.attovia.com

Top Investors: Cormorant Asset Management, Marshall Wace, Frazier Life Sciences, Redmile Group, Goldman Sachs Asset Management

Description:

Attovia Therapeutics is a biotherapeutics pipeline developer focused on immune-mediated illness and oncology. The company uses the nanobody platform to create tiny format binders with low picomolar affinity, increased selectivity, quicker internalization, and rapid tissue penetration, thereby assisting cancer patients' treatment.